NCT05843188 2025-12-09Study of Hydroxychloroquine With FOLFIRI and Bevacizumab in DTP-high Metastatic Colorectal CancerUniversity Health Network, TorontoPhase 2 Active not recruiting155 enrolled
NCT05576896 2025-10-20Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer RefractoryNorthwestern UniversityPhase 2 Recruiting43 enrolled